The continuous blood glucose monitoring market size has grown strongly in recent years. It will grow from $14.87 billion in 2025 to $16.29 billion in 2026 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to limited availability of real-time glucose monitoring, reliance on finger-prick blood testing, increasing prevalence of diabetes, rising hospital and clinical monitoring, early adoption of insulin pump therapy.
The continuous blood glucose monitoring market size is expected to see rapid growth in the next few years. It will grow to $26.11 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to advancements in implantable and flash glucose sensors, growing homecare and remote monitoring solutions, integration with digital health platforms, increasing awareness of diabetes self-management, adoption of ai-based predictive analytics. Major trends in the forecast period include rising adoption of continuous glucose monitoring devices, integration with smartphone apps and wearables, expansion of homecare diagnostics for diabetes management, development of minimally invasive and implantable sensors, growing focus on real-time data analytics and alerts.
The increase in the prevalence of diabetes is anticipated to support the expansion of the continuous blood glucose monitoring market going forward. Diabetes is a health condition that occurs when blood glucose levels fluctuate abnormally within the body. Blood glucose monitoring devices assist in identifying trends and patterns, providing a comprehensive view of a patient’s diabetic condition. For example, in June 2024, according to the National Health Service (NHS), a UK-based government department, the number of individuals under 40 living with diabetes increased from 173,166 in 2022 to 216,440 in 2023. This notable rise highlights a concerning trend among younger populations and reflects a rapid escalation in diabetes prevalence. Consequently, the increasing prevalence of diabetes is strengthening demand for continuous blood glucose monitoring solutions.
Leading companies operating in the continuous blood glucose monitoring (CGM) market are increasingly focusing on advanced CGM systems to enhance real-time glucose tracking, improve patient convenience, and support better diabetes management. A CGM system continuously measures glucose levels throughout the day and night, providing real-time readings at frequent intervals. For example, in August 2025, Abbott Laboratories, a US-based healthcare company, launched the FreeStyle Libre 2 Plus system, an advanced CGM sensor that delivers glucose readings every minute directly to compatible smartphones without manual scanning. The system includes optional glucose alerts, extended wear duration, and integration with Abbott’s digital health ecosystem, supporting improved glycemic control and reduced reliance on finger-stick testing.
In May 2023, Medtronic PLC., an Ireland-based medical device company, acquired EOFlow for an undisclosed amount. This acquisition is intended to reinforce Medtronic’s diabetes product portfolio and expand its ability to deliver comprehensive support to a broader global population managing diabetes within a unified Medtronic ecosystem. EOFlow Co. Ltd. is a South Korea-based manufacturer of the EOPatch insulin patch pump.
Major companies operating in the continuous blood glucose monitoring market are F. Hoffmann-La Roche Ltd., Medtronic plc., Abbott Laboratories, GlySens Inc., Senseonics Holdings Inc., Glysure Limited, Nemaura Medical Inc., Tandem Diabetes Care Inc., Ypsomed Holding AG, Orsense Ltd., Dexcom Inc., Insulet Corporation, Medtrum Technologies Inc., Beta Bionics Inc., Bigfoot Biomedical Inc., GluSense Ltd., i-SENS Inc., Osang Healthcare Co Ltd., WaveForm Technologies, EyeSense GmbH, Calisto Medical, Biorasis, DirectSens GmbH, Ultrahuman Healthcare.
North America was the largest region in the continuous blood glucose monitoring market in 2025. The regions covered in the continuous blood glucose monitoring market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the continuous blood glucose monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the continuous blood glucose monitoring market by increasing costs for imported sensors, transmitters, and insulin pumps, leading to higher device prices and supply chain adjustments. Segments such as implantable sensors and wireless transmitters are most affected, with Asia-Pacific regions like China and India facing the highest import duties. While tariffs have posed challenges for global distribution, they have also encouraged local manufacturing, innovation in device design, and investment in domestic production capacities.
The continuous blood glucose monitoring market research report is one of a series of new reports that provides continuous blood glucose monitoring market statistics, including continuous blood glucose monitoring industry global market size, regional shares, competitors with a continuous blood glucose monitoring market share, detailed continuous blood glucose monitoring market segments, market trends and opportunities, and any further data you may need to thrive in the continuous blood glucose monitoring industry. This continuous blood glucose monitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Continuous glucose monitoring (CGM) uses a small sensor placed under the skin to track glucose levels continuously. It provides real-time readings and alerts for high or low glucose levels, helping people with diabetes manage blood sugar more effectively.
The key components of continuous blood glucose monitoring devices include insulin pumps, sensors, transmitters, and receivers. Insulin pumps are compact computerized devices programmed to deliver precise doses of insulin to diabetic patients at scheduled intervals. These devices are used by patients with type 1 diabetes, type 2 diabetes, gestational diabetes, and critically ill patients and are utilized by end users such as hospitals, homecare diagnostic providers, and others.
The continuous blood glucose monitoring market consists of sales of real-time continuous glucose monitoring, and intermittently scanned continuous glucose monitoring. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The continuous blood glucose monitoring market size is expected to see rapid growth in the next few years. It will grow to $26.11 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to advancements in implantable and flash glucose sensors, growing homecare and remote monitoring solutions, integration with digital health platforms, increasing awareness of diabetes self-management, adoption of ai-based predictive analytics. Major trends in the forecast period include rising adoption of continuous glucose monitoring devices, integration with smartphone apps and wearables, expansion of homecare diagnostics for diabetes management, development of minimally invasive and implantable sensors, growing focus on real-time data analytics and alerts.
The increase in the prevalence of diabetes is anticipated to support the expansion of the continuous blood glucose monitoring market going forward. Diabetes is a health condition that occurs when blood glucose levels fluctuate abnormally within the body. Blood glucose monitoring devices assist in identifying trends and patterns, providing a comprehensive view of a patient’s diabetic condition. For example, in June 2024, according to the National Health Service (NHS), a UK-based government department, the number of individuals under 40 living with diabetes increased from 173,166 in 2022 to 216,440 in 2023. This notable rise highlights a concerning trend among younger populations and reflects a rapid escalation in diabetes prevalence. Consequently, the increasing prevalence of diabetes is strengthening demand for continuous blood glucose monitoring solutions.
Leading companies operating in the continuous blood glucose monitoring (CGM) market are increasingly focusing on advanced CGM systems to enhance real-time glucose tracking, improve patient convenience, and support better diabetes management. A CGM system continuously measures glucose levels throughout the day and night, providing real-time readings at frequent intervals. For example, in August 2025, Abbott Laboratories, a US-based healthcare company, launched the FreeStyle Libre 2 Plus system, an advanced CGM sensor that delivers glucose readings every minute directly to compatible smartphones without manual scanning. The system includes optional glucose alerts, extended wear duration, and integration with Abbott’s digital health ecosystem, supporting improved glycemic control and reduced reliance on finger-stick testing.
In May 2023, Medtronic PLC., an Ireland-based medical device company, acquired EOFlow for an undisclosed amount. This acquisition is intended to reinforce Medtronic’s diabetes product portfolio and expand its ability to deliver comprehensive support to a broader global population managing diabetes within a unified Medtronic ecosystem. EOFlow Co. Ltd. is a South Korea-based manufacturer of the EOPatch insulin patch pump.
Major companies operating in the continuous blood glucose monitoring market are F. Hoffmann-La Roche Ltd., Medtronic plc., Abbott Laboratories, GlySens Inc., Senseonics Holdings Inc., Glysure Limited, Nemaura Medical Inc., Tandem Diabetes Care Inc., Ypsomed Holding AG, Orsense Ltd., Dexcom Inc., Insulet Corporation, Medtrum Technologies Inc., Beta Bionics Inc., Bigfoot Biomedical Inc., GluSense Ltd., i-SENS Inc., Osang Healthcare Co Ltd., WaveForm Technologies, EyeSense GmbH, Calisto Medical, Biorasis, DirectSens GmbH, Ultrahuman Healthcare.
North America was the largest region in the continuous blood glucose monitoring market in 2025. The regions covered in the continuous blood glucose monitoring market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the continuous blood glucose monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the continuous blood glucose monitoring market by increasing costs for imported sensors, transmitters, and insulin pumps, leading to higher device prices and supply chain adjustments. Segments such as implantable sensors and wireless transmitters are most affected, with Asia-Pacific regions like China and India facing the highest import duties. While tariffs have posed challenges for global distribution, they have also encouraged local manufacturing, innovation in device design, and investment in domestic production capacities.
The continuous blood glucose monitoring market research report is one of a series of new reports that provides continuous blood glucose monitoring market statistics, including continuous blood glucose monitoring industry global market size, regional shares, competitors with a continuous blood glucose monitoring market share, detailed continuous blood glucose monitoring market segments, market trends and opportunities, and any further data you may need to thrive in the continuous blood glucose monitoring industry. This continuous blood glucose monitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Continuous glucose monitoring (CGM) uses a small sensor placed under the skin to track glucose levels continuously. It provides real-time readings and alerts for high or low glucose levels, helping people with diabetes manage blood sugar more effectively.
The key components of continuous blood glucose monitoring devices include insulin pumps, sensors, transmitters, and receivers. Insulin pumps are compact computerized devices programmed to deliver precise doses of insulin to diabetic patients at scheduled intervals. These devices are used by patients with type 1 diabetes, type 2 diabetes, gestational diabetes, and critically ill patients and are utilized by end users such as hospitals, homecare diagnostic providers, and others.
The continuous blood glucose monitoring market consists of sales of real-time continuous glucose monitoring, and intermittently scanned continuous glucose monitoring. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Continuous Blood Glucose Monitoring Market Characteristics
3. Continuous Blood Glucose Monitoring Market Supply Chain Analysis
4. Global Continuous Blood Glucose Monitoring Market Trends and Strategies
5. Continuous Blood Glucose Monitoring Market Analysis of End Use Industries
7. Global Continuous Blood Glucose Monitoring Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Continuous Blood Glucose Monitoring Total Addressable Market (TAM) Analysis for the Market
9. Continuous Blood Glucose Monitoring Market Segmentation
10. Continuous Blood Glucose Monitoring Market Regional and Country Analysis
11. Asia-Pacific Continuous Blood Glucose Monitoring Market
12. China Continuous Blood Glucose Monitoring Market
13. India Continuous Blood Glucose Monitoring Market
14. Japan Continuous Blood Glucose Monitoring Market
15. Australia Continuous Blood Glucose Monitoring Market
16. Indonesia Continuous Blood Glucose Monitoring Market
17. South Korea Continuous Blood Glucose Monitoring Market
18. Taiwan Continuous Blood Glucose Monitoring Market
19. South East Asia Continuous Blood Glucose Monitoring Market
20. Western Europe Continuous Blood Glucose Monitoring Market
21. UK Continuous Blood Glucose Monitoring Market
22. Germany Continuous Blood Glucose Monitoring Market
23. France Continuous Blood Glucose Monitoring Market
24. Italy Continuous Blood Glucose Monitoring Market
25. Spain Continuous Blood Glucose Monitoring Market
26. Eastern Europe Continuous Blood Glucose Monitoring Market
27. Russia Continuous Blood Glucose Monitoring Market
28. North America Continuous Blood Glucose Monitoring Market
29. USA Continuous Blood Glucose Monitoring Market
30. Canada Continuous Blood Glucose Monitoring Market
31. South America Continuous Blood Glucose Monitoring Market
32. Brazil Continuous Blood Glucose Monitoring Market
33. Middle East Continuous Blood Glucose Monitoring Market
34. Africa Continuous Blood Glucose Monitoring Market
36. Continuous Blood Glucose Monitoring Market Competitive Landscape and Company Profiles
37. Continuous Blood Glucose Monitoring Market Other Major and Innovative Companies
40. Continuous Blood Glucose Monitoring Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Continuous Blood Glucose Monitoring Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses continuous blood glucose monitoring market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for continuous blood glucose monitoring? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The continuous blood glucose monitoring market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Component: Insulin Pumps; Sensors; Transmitters; Receivers2) By Application: Type 1 Diabetic Patients; Type 2 Diabetic Patients; Gestational Diabetes; Critical Care Patients
3) By End User: Hospitals; Homecare Diagnostics; Other End Users
Subsegments:
1) By Insulin Pumps: Tubeless Insulin Pumps; Tubed Insulin Pumps; Patch Pumps2) By Sensors: Continuous Glucose Monitoring Sensors; Flash Glucose Monitoring Sensors; Implantable Sensors
3) By Transmitters: Integrated Transmitters; Wireless Transmitters; Bluetooth-Enabled Transmitters
4) By Receivers: Standalone Receivers; Smartphone Apps; Integrated Devices
Companies Mentioned: F. Hoffmann-La Roche Ltd.; Medtronic plc.; Abbott Laboratories; GlySens Inc.; Senseonics Holdings Inc.; Glysure Limited; Nemaura Medical Inc.; Tandem Diabetes Care Inc.; Ypsomed Holding AG; Orsense Ltd.; Dexcom Inc.; Insulet Corporation; Medtrum Technologies Inc.; Beta Bionics Inc.; Bigfoot Biomedical Inc.; GluSense Ltd.; i-SENS Inc.; Osang Healthcare Co Ltd.; WaveForm Technologies; EyeSense GmbH; Calisto Medical; Biorasis; DirectSens GmbH; Ultrahuman Healthcare
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Continuous Blood Glucose Monitoring market report include:- F. Hoffmann-La Roche Ltd.
- Medtronic plc.
- Abbott Laboratories
- GlySens Inc.
- Senseonics Holdings Inc.
- Glysure Limited
- Nemaura Medical Inc.
- Tandem Diabetes Care Inc.
- Ypsomed Holding AG
- Orsense Ltd.
- Dexcom Inc.
- Insulet Corporation
- Medtrum Technologies Inc.
- Beta Bionics Inc.
- Bigfoot Biomedical Inc.
- GluSense Ltd.
- i-SENS Inc.
- Osang Healthcare Co Ltd.
- WaveForm Technologies
- EyeSense GmbH
- Calisto Medical
- Biorasis
- DirectSens GmbH
- Ultrahuman Healthcare
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 16.29 Billion |
| Forecasted Market Value ( USD | $ 26.11 Billion |
| Compound Annual Growth Rate | 12.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
